Yi-Kei Tse

998 total citations
35 papers, 666 citations indexed

About

Yi-Kei Tse is a scholar working on Epidemiology, Cardiology and Cardiovascular Medicine and Finance. According to data from OpenAlex, Yi-Kei Tse has authored 35 papers receiving a total of 666 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 9 papers in Cardiology and Cardiovascular Medicine and 8 papers in Finance. Recurrent topics in Yi-Kei Tse's work include Market Dynamics and Volatility (5 papers), Financial Risk and Volatility Modeling (5 papers) and Diabetes Treatment and Management (5 papers). Yi-Kei Tse is often cited by papers focused on Market Dynamics and Volatility (5 papers), Financial Risk and Volatility Modeling (5 papers) and Diabetes Treatment and Management (5 papers). Yi-Kei Tse collaborates with scholars based in Singapore, Hong Kong and China. Yi-Kei Tse's co-authors include Albert K. Tsui, Hung‐Fat Tse, Q W Ren, Mei‐Zhen Wu, Kai‐Hang Yiu, Andraay Leung, K. S. Leung, P. C. Leung, Wing‐Hoi Cheung and Carolyn S.P. Lam and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Yi-Kei Tse

30 papers receiving 605 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi-Kei Tse Singapore 11 401 380 175 50 49 35 666
Junghoon Lee South Korea 11 176 0.4× 82 0.2× 32 0.2× 12 0.2× 39 429
Conall O’Sullivan Ireland 8 41 0.1× 75 0.2× 24 0.1× 2 0.0× 101 2.1× 22 265
Thorsten Schmidt Germany 13 49 0.1× 191 0.5× 9 0.1× 79 1.6× 6 0.1× 32 344
Andrea Bucci Italy 8 119 0.3× 93 0.2× 10 0.1× 3 0.1× 8 0.2× 34 259
Laura A. Tuttle United States 14 238 0.6× 296 0.8× 45 0.3× 3 0.1× 29 592
Dan Zhu China 12 57 0.1× 49 0.1× 18 0.1× 1 0.0× 28 0.6× 84 525
Juan Carlos Pardo–Fernández Spain 10 40 0.1× 28 0.1× 11 0.1× 4 0.1× 8 0.2× 23 323
Paul Boothe Canada 10 402 1.0× 342 0.9× 372 2.1× 29 640
Michael J. Hartley United States 13 117 0.3× 42 0.1× 73 0.4× 2 0.0× 1 0.0× 34 516
Hans C. Blomqvist Sweden 15 67 0.2× 21 0.1× 65 0.4× 1 0.0× 5 0.1× 69 1.1k

Countries citing papers authored by Yi-Kei Tse

Since Specialization
Citations

This map shows the geographic impact of Yi-Kei Tse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi-Kei Tse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi-Kei Tse more than expected).

Fields of papers citing papers by Yi-Kei Tse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi-Kei Tse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi-Kei Tse. The network helps show where Yi-Kei Tse may publish in the future.

Co-authorship network of co-authors of Yi-Kei Tse

This figure shows the co-authorship network connecting the top 25 collaborators of Yi-Kei Tse. A scholar is included among the top collaborators of Yi-Kei Tse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi-Kei Tse. Yi-Kei Tse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Mei‐Zhen, Ran Guo, Chanchal Chandramouli, et al.. (2025). Urinary tract infection and continuation of sodium-glucose cotransporter-2 inhibitors in diabetic patients. European Heart Journal.
2.
Teng, Tiew‐Hwa Katherine, Wouter Ouwerkerk, Yi-Kei Tse, et al.. (2025). Triglyceride levels and its association with all-cause mortality and cardiovascular outcomes among patients with heart failure. Nature Communications. 16(1). 1408–1408. 5 indexed citations
3.
Cheang, Iokfai, Ying X. Gue, Mei‐Zhen Wu, et al.. (2025). Cardiovascular risks associated with adjuvant endocrine therapy in women with breast cancer: a population-based cohort study. BMC Cancer. 25(1). 1063–1063. 1 indexed citations
4.
Tam, N.F.Y., Steven Jing‐Liang Xu, Wing Yin Mo, et al.. (2024). Habitat variations of sediment microbial community structure and functions and the influential environmental factors in a Ramsar protected wetland in South China. Marine Pollution Bulletin. 209(Pt A). 117166–117166.
5.
Ren, Q W, Tiew‐Hwa Katherine Teng, Yi-Kei Tse, et al.. (2024). Statins and risks of dementia among patients with heart failure: a population-based retrospective cohort study in Hong Kong. The Lancet Regional Health - Western Pacific. 44. 101006–101006. 13 indexed citations
6.
Ren, Q W, Tiew‐Hwa Katherine Teng, Yi-Kei Tse, et al.. (2023). Incidence, Clinical Correlates, and Prognostic Impact of Dementia in Heart Failure. JACC Asia. 3(1). 108–119. 9 indexed citations
7.
Tse, Yi-Kei, Hang‐Long Li, Q W Ren, et al.. (2023). Morphological and functional types of tricuspid regurgitation: prognostic value in patients undergoing tricuspid annuloplasty during left-sided valvular surgery. Clinical Research in Cardiology. 112(10). 1463–1474. 2 indexed citations
8.
Wang, Run, Mei‐Zhen Wu, Q W Ren, et al.. (2023). Clinical Value of Computational Angiography-derived Fractional Flow Reserve in Stable Coronary Artery Disease. Journal of Cardiovascular Translational Research. 16(5). 1166–1176. 3 indexed citations
9.
Li, Hang‐Long, Yi-Kei Tse, Xue Li, et al.. (2022). Pre-admission and In-Hospital Statin Use is Associated With Reduced Short-Term Mortality in Infective Endocarditis. Mayo Clinic Proceedings. 98(2). 252–265. 4 indexed citations
10.
Wu, Mei‐Zhen, Chanchal Chandramouli, Pui‐Fai Wong, et al.. (2022). Risk of sepsis and pneumonia in patients initiated on SGLT2 inhibitors and DPP-4 inhibitors. Diabetes & Metabolism. 48(6). 101367–101367. 26 indexed citations
11.
Huang, Jiayi, Yi-Kei Tse, Hang‐Long Li, et al.. (2022). Prediabetes Is Associated With Increased Risk of Heart Failure Among Patients With Atrial Fibrillation. Diabetes Care. 46(1). 190–196. 11 indexed citations
12.
Li, Hang‐Long, Jasper Tromp, K. Teramoto, et al.. (2022). Temporal trends and patterns of infective endocarditis in a Chinese population: A territory-wide study in Hong Kong (2002–2019). The Lancet Regional Health - Western Pacific. 22. 100417–100417. 23 indexed citations
13.
Li, Hang‐Long, Gregory Y.H. Lip, Qi Feng, et al.. (2021). Correction to: Sodium–glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systematic review and meta‑analysis. Cardiovascular Diabetology. 20(1). 177–177. 2 indexed citations
14.
15.
Tse, Yi-Kei & Xiaodong Zhang. (2002). The Variance Ratio Test with Stable Paretian Errors. Journal of Time Series Analysis. 23(1). 117–126. 4 indexed citations
16.
Zhang, Xiaodong, Yi-Kei Tse, & Wai‐Sum Chan. (2000). DETECTING STRUCTURAL CHANGES USING GENETIC PROGRAMMING WITH AN APPLICATION TO THE GREATER-CHINA STOCK MARKETS. 370–384. 1 indexed citations
17.
Tse, Yi-Kei. (1998). An Empirical Analysis of the Stochastic Behaviour of Short‐Term Interest Rates in Singapore. Asian Economic Journal. 12(1). 23–34.
18.
Tse, Yi-Kei. (1986). The spot and forward exchange rates: some empirical evidence of Singapore. Applied Economics. 18(3). 319–331. 3 indexed citations
19.
Tse, Yi-Kei. (1984). Testing for linear and log-linear regressions with heteroscedasticity. Economics Letters. 16(1-2). 63–69. 2 indexed citations
20.
Hui, Yi & Yi-Kei Tse. (1984). A Physical Interpretation of the Maximum Likelihood Estimation of a Linear Functional Relationship Model. Journal of the Royal Statistical Society Series D (The Statistician). 33(2). 239–239. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026